UMGCC Paul Calabresi Clinical Oncology Training Program

UMGCC Paul Calabresi 临床肿瘤学培训计划

• 批准号: 8141280
• 负责人: EDWARD A. SAUSVILLE
• 金额: --
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-05 至 2014-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8141280
• 关键词: Applications Grants; Appointment; Area; Baltimore; Cancer Center; Clinical; Clinical Oncology; Clinical Protocols; Clinical Research; Clinical Trials; Combined Modality Therapy; Commit; Dental Assistants; Development; Doctor of Medicine; Doctor of Philosophy; Educational Curriculum; Faculty; Funding; Goals; K-Series Research Career Programs; Laws; Learning; Malignant Neoplasms; Maryland; Master of Science; Mentors; Mentorship; NCI Scholars Program; Peer Review; Pharmacy facility; Population; Population Sciences; Postdoctoral Fellow; Public Health Schools; Resource Sharing; Schools; Secure; Training; Training Programs; Translational Research; Treatment-Related Cancer; Underrepresented Minority; Universities; anticancer research; base; career; career development; drug development; drug discovery; experience; medical schools; multidisciplinary; programs; success; treatment strategy

DESCRIPTION (provided by applicant): The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) Paul Calabresi Clinical Oncology Training Program will support career development and training of Calabresi Scholars in clinical oncology translational research. UMGCC Calabresi Scholars will have an M.D., D.O., or equivalent clinical degree, have finished clinical training, and be ready for a junior faculty appointment. In addition, Ph.D.s, Pharm.D.s, or R.N.s with a Ph.D. who have finished at least one post-doctoral experience and who are committing to a career in clinical oncology translational research are eligible. The themes to be promoted in the UMGCC Scholars Program reflect areas of UMGCC strength: multimodality treatment strategies for cancer; drug discovery and development; and clinical cancer research in underserved minority populations. The Program will provide a didactic learning experience leading to a Master of Science in Clinical Research; a clinical research experience that will focus each Scholar's development of a cancer therapy - related clinical trial to answer a hypothesis-based clinical research question with translational endpoints; and a basic/population science activity which will tie to the clinical protocol translational question. The Scholars will be assisted in these goals by each Scholar having a Mentorship Committee consisting of a Clinical Mentor, a Basic/Population Science Mentor, and a Biostatistical Mentor. In addition, an independent Grant Application Development Committee will be formed for each Scholar, unrelated to the Scholar's Mentor Committee, to promote success of the Scholar in securing independent, peer reviewed funding. The UMGCC Program is distinguished by a number of features including 1) participation and support from six professional Schools at the University of Maryland, Baltimore (UMB Schools of Medicine, Pharmacy, Nursing, Dental, Law and the newly formed UMB School of Public Health); 2) experienced, well-funded multidisciplinary mentors; 3) the strength of UMs existing K30 Clinical Research Curriculum for the Calabresi Scholars' didactic training; 4) close coordination and the sharing of resources with existing K12s, particularly the UM Multidisciplinary Clinical Research Career Development Award; 5) a clinical research base consisting of >150 open and accruing clinical trials reflecting multidisciplinary clinical expertise and Institutional commitment to support clinical research.

描述（由申请人提供）：马里兰大学 Marlene 和 Stewart Greenebaum 癌症中心 (UMGCC) Paul Calabresi 临床肿瘤学培训计划将支持 Calabresi 学者在临床肿瘤学转化研究方面的职业发展和培训。 UMGCC Calabresi 学者将拥有医学博士、医学博士或同等临床学位，已完成临床培训，并为初级教师任命做好准备。此外，博士、药学博士或拥有博士学位的注册护士。已完成至少一次博士后经历并致力于临床肿瘤学转化研究职业的人符合资格。 UMGCC 学者计划推广的主题反映了 UMGCC 的优势领域：癌症的多模式治疗策略；药物发现和开发；以及服务不足的少数群体的临床癌症研究。该计划将提供教学学习经验，最终获得临床研究理学硕士学位；临床研究经验，重点是每位学者开发癌症治疗相关的临床试验，以回答基于假设的临床研究问题和转化终点；以及与临床方案转化问题相关的基础/人口科学活动。每位学者都设有一个由临床导师、基础/人口科学导师和生物统计导师组成的导师委员会，协助学者实现这些目标。此外，将为每位学者成立一个独立的拨款申请开发委员会，与学者导师委员会无关，以促进学者成功获得独立的同行评审资金。 UMGCC 计划具有许多特点，包括 1) 来自马里兰大学巴尔的摩分校六个专业学院（UMB 医学院、药学院、护理学院、牙科学院、法学院和新成立的 UMB 公共卫生学院）的参与和支持; 2）经验丰富、资金雄厚的多学科导师； 3) UM现有的K30临床研究课程对于卡拉布雷西学者教学培训的优势； 4）与现有的K12密切协调和资源共享，特别是UM多学科临床研究职业发展奖； 5) 临床研究基地，由超过 150 个开放和累积的临床试验组成，反映多学科临床专业知识和支持临床研究的机构承诺。